LINC00929

Across TCGA pan-cancer cohorts, LINC00929 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of LINC00929’s most consistent transcriptional readouts.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where LINC00929 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC00929 is over-expressed in tumor, although a few such as LUSC and LUAD show the opposite, repressed pattern.

LUSC, BRCA, and LUAD are the cancer types where LINC00929 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC00929 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUSC	All	All	−0.022	<.001	5	view →
BRCA	All	II,III,IV	+0.007	.009	4	view →
LUAD	Female	All	−0.017	.017	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

LINC00929–LUSC

Open the LUSC breakdown →